Masimo (MASI) Earnings and Revenues Beat Estimates in Q2
Masimo (MASI) continues to gain from key Product segment, which witnessed solid growth in Q2.
Zacks · 07/29 11:42
How Masimo Beat Expectations in Q2
MotleyFool.com · 07/29 10:20
Masimo's (MASI) CEO Joe Kiani on Q2 2020 Results - Earnings Call Transcript SA Transcripts
Seeking Alpha · 07/29 01:44
Dexcom Stock Up, Masimo Stock Slips On Medtech Earnings Beats
Medtech companies Masimo and Dexcom late Tuesday reported second-quarter earnings that beat expectations, but only Dexcom stock rose as Masimo declined to provide guidance for the year.